Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +7.14% | -.--% | -1.64% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
Sales 2021 | 1.16B 160M | Sales 2022 | 1.24B 172M | Capitalization | 2.97B 410M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.15M | Net income 2022 | 501M 69.19M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 839M | Net cash position 2022 | 6.66B 920M | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
1 day | +7.14% | ||
1 month | -4.00% | ||
3 months | -20.00% | ||
Current year | -1.64% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.2 | +7.14% | 2,300 |
24-05-29 | 1.12 | +1.82% | 18,208 |
24-05-28 | 1.1 | -8.33% | 125 |
Delayed Quote OTC Markets, May 31, 2024 at 09:34 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-1.64% | 161M | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-1.13% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- CORBF Stock